Advertisement
Screener

REPLIGEN CORP (RGEN) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

3.0 / 5 stars · 72/120 Roast Me

REPLIGEN CORP Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

REPLIGEN CORP (RGEN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 73.78 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Shareholders' Equity

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-07-29

  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2026-06-30 was 25.59K shares, a 5.50% decline year-over-year.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2026-03-31 was 48.19K shares, a 59.14% increase year-over-year.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-12-31 was 2.14K shares, a 43.13% decline year-over-year.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2025-09-30 was 3.91K shares, a 75.96% decline year-over-year.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2025 was 63.42K shares, a 21.49% decline from fiscal 2024.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 80.78K shares, a 10.55% decline from fiscal 2023.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 90.31K shares, a 2.81% increase from fiscal 2022.
  • REPLIGEN CORP share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2022 was 87.84K shares, a 126.25% increase from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month
2026-06-3025.59K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
73.78K shares
10-Q · filed 2026-07-29
75.92K shares
derived: sum of 3 quarters · filed 2026-07-29
79.84K shares
derived: sum of 4 quarters · filed 2026-07-29
2026-03-3148.19K shares
10-Q · filed 2026-05-06
50.33K shares
derived: sum of 2 quarters · filed 2026-05-06
54.25K shares
derived: sum of 3 quarters · filed 2026-05-06
81.33K shares
derived: sum of 4 quarters · filed 2026-05-06
2025-12-312.14K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
6.06K shares
derived: sum of 2 quarters · filed 2026-02-26
33.14K shares
derived: sum of 3 quarters · filed 2026-02-26
63.42K shares
10-K · filed 2026-02-26
2025-09-303.91K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
31.00K shares
derived: sum of 2 quarters · filed 2025-11-04
61.28K shares
10-Q · filed 2025-11-04
65.05K shares
derived: sum of 4 quarters · filed 2025-11-04
2025-06-3027.08K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
57.36K shares
10-Q · filed 2025-08-07
61.13K shares
derived: sum of 3 quarters · filed 2025-08-07
77.41K shares
derived: sum of 4 quarters · filed 2025-08-07
2025-03-3130.28K shares
10-Q · filed 2025-04-29
34.05K shares
derived: sum of 2 quarters · filed 2025-04-29
50.33K shares
derived: sum of 3 quarters · filed 2025-04-29
71.53K shares
derived: sum of 4 quarters · filed 2025-04-29
2024-12-313.77K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
20.05K shares
derived: sum of 2 quarters · filed 2025-03-14
41.25K shares
derived: sum of 3 quarters · filed 2025-03-14
80.78K shares
10-K · filed 2025-03-14
2024-09-3016.28K shares
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2024-11-18
37.49K shares
derived: sum of 2 quarters · filed 2024-11-18
77.01K shares
10-Q · filed 2024-11-18
101.25K shares
derived: sum of 4 quarters · filed 2024-11-18
2024-06-3021.21K shares
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18
60.74K shares
10-Q/A · filed 2024-11-18
84.97K shares
derived: sum of 3 quarters · filed 2024-11-18
95.50K shares
derived: sum of 4 quarters · filed 2024-11-18
2024-03-3139.53K shares
10-Q/A · filed 2024-11-18
63.76K shares
derived: sum of 2 quarters · filed 2024-11-18
74.29K shares
derived: sum of 3 quarters · filed 2024-11-18
86.85K shares
derived: sum of 4 quarters · filed 2024-11-18
2023-12-3124.24K shares
derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-11-18
34.76K shares
derived: sum of 2 quarters · filed 2024-11-18
47.32K shares
derived: sum of 3 quarters · filed 2024-11-18
90.31K shares
10-K/A · filed 2024-11-18
2023-09-3010.52K shares
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18
23.09K shares
derived: sum of 2 quarters · filed 2024-11-18
66.07K shares
10-Q/A · filed 2024-11-18
106.07K shares
derived: sum of 4 quarters · filed 2024-11-18
2023-06-3012.56K shares
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18
55.55K shares
10-Q/A · filed 2024-11-18
95.55K shares
derived: sum of 3 quarters · filed 2024-11-18
95.55K shares
derived: sum of 4 quarters · filed 2024-11-18
2023-03-3142.98K shares
10-Q/A · filed 2024-11-18
82.98K shares
derived: sum of 2 quarters · filed 2024-11-18
82.98K shares
derived: sum of 3 quarters · filed 2024-11-18
96.35K shares
derived: sum of 4 quarters · filed 2024-11-18
2022-12-3140.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
40.00K shares
derived: sum of 2 quarters · filed 2023-02-22
53.37K shares
derived: sum of 3 quarters · filed 2023-02-22
87.84K shares
10-K · filed 2023-02-22
2022-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
13.37K shares
derived: sum of 2 quarters · filed 2022-11-01
47.84K shares
10-Q · filed 2022-11-01
47.84K shares
derived: sum of 4 quarters · filed 2022-11-01
2022-06-3013.37K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
47.84K shares
10-Q · filed 2022-08-02
47.84K shares
derived: sum of 3 quarters · filed 2022-08-02
57.84K shares
derived: sum of 4 quarters · filed 2022-08-02
2022-03-3134.47K shares
10-Q · filed 2022-04-27
34.47K shares
derived: sum of 2 quarters · filed 2022-04-27
44.47K shares
derived: sum of 3 quarters · filed 2022-04-27
51.75K shares
derived: sum of 4 quarters · filed 2022-04-27
2021-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17
10.00K shares
derived: sum of 2 quarters · filed 2022-02-17
17.28K shares
derived: sum of 3 quarters · filed 2022-02-17
38.82K shares
10-K · filed 2022-02-17
2021-09-3010.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
17.28K shares
derived: sum of 2 quarters · filed 2021-10-28
38.82K shares
10-Q · filed 2021-10-28
48.82K shares
derived: sum of 4 quarters · filed 2021-10-28
2021-06-307.28K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27
28.82K shares
10-Q · filed 2021-07-27
38.82K shares
derived: sum of 3 quarters · filed 2021-07-27
50.82K shares
derived: sum of 4 quarters · filed 2021-07-27
2021-03-3121.55K shares
10-Q · filed 2021-05-04
31.55K shares
derived: sum of 2 quarters · filed 2021-05-04
43.55K shares
derived: sum of 3 quarters · filed 2021-05-04
75.41K shares
derived: sum of 4 quarters · filed 2021-05-04
2020-12-3110.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
22.00K shares
derived: sum of 2 quarters · filed 2021-02-24
53.86K shares
derived: sum of 3 quarters · filed 2021-02-24
79.70K shares
10-K · filed 2021-02-24
2020-09-3012.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
43.86K shares
derived: sum of 2 quarters · filed 2020-11-05
69.70K shares
10-Q · filed 2020-11-05
79.70K shares
derived: sum of 4 quarters · filed 2020-11-05
2020-06-3031.86K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
57.70K shares
10-Q · filed 2020-07-30
67.70K shares
derived: sum of 3 quarters · filed 2020-07-30
67.70K shares
derived: sum of 4 quarters · filed 2020-07-30
2020-03-3125.84K shares
10-Q · filed 2020-05-06
35.84K shares
derived: sum of 2 quarters · filed 2020-05-06
35.84K shares
derived: sum of 3 quarters · filed 2020-05-06
49.33K shares
derived: sum of 4 quarters · filed 2020-05-06
2019-12-3110.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
10.00K shares
derived: sum of 2 quarters · filed 2020-02-26
23.50K shares
derived: sum of 3 quarters · filed 2020-02-26
55.00K shares
10-K · filed 2020-02-26
2019-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
13.50K shares
derived: sum of 2 quarters · filed 2019-10-31
45.00K shares
10-Q · filed 2019-10-31
55.00K shares
derived: sum of 4 quarters · filed 2019-10-31
2019-06-3013.50K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
45.00K shares
10-Q · filed 2019-08-01
55.00K shares
derived: sum of 3 quarters · filed 2019-08-01
65.00K shares
derived: sum of 4 quarters · filed 2019-08-01
2019-03-3131.50K shares
10-Q · filed 2019-05-09
41.50K shares
derived: sum of 2 quarters · filed 2019-05-09
51.50K shares
derived: sum of 3 quarters · filed 2019-05-09
82.64K shares
derived: sum of 4 quarters · filed 2019-05-09
2018-12-3110.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01
20.00K shares
derived: sum of 2 quarters · filed 2019-03-01
51.15K shares
derived: sum of 3 quarters · filed 2019-03-01
449.68K shares
10-K · filed 2019-03-01
2018-09-3010.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
41.15K shares
derived: sum of 2 quarters · filed 2018-11-01
439.68K shares
10-Q · filed 2018-11-01
439.68K shares
derived: sum of 4 quarters · filed 2018-11-01
2018-06-3031.15K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
429.68K shares
10-Q · filed 2018-08-02
429.68K shares
derived: sum of 3 quarters · filed 2018-08-02
429.68K shares
derived: sum of 4 quarters · filed 2018-08-02
2018-03-31398.53K shares
10-Q · filed 2018-05-08
398.53K shares
derived: sum of 2 quarters · filed 2018-05-08
398.53K shares
derived: sum of 3 quarters · filed 2018-05-08
414.16K shares
derived: sum of 4 quarters · filed 2018-05-08
2017-12-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22
0.00 shares
derived: sum of 2 quarters · filed 2018-02-22
15.63K shares
derived: sum of 3 quarters · filed 2018-02-22
101.84K shares
10-K · filed 2018-02-22
2017-09-300.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
15.63K shares
derived: sum of 2 quarters · filed 2017-11-09
101.84K shares
10-Q · filed 2017-11-09
-80.54K shares
derived: sum of 4 quarters · filed 2017-11-09
2017-06-3015.63K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
101.84K shares
10-Q · filed 2017-08-03
-80.54K shares
derived: sum of 3 quarters · filed 2017-08-03
-45.74K shares
derived: sum of 4 quarters · filed 2017-08-03
2017-03-3186.22K shares
10-Q · filed 2017-05-04
-96.17K shares
derived: sum of 2 quarters · filed 2017-05-04
-61.37K shares
derived: sum of 3 quarters · filed 2017-05-04
25.61K shares
derived: sum of 4 quarters · filed 2017-05-04
2016-12-31-182.38K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23
-147.58K shares
derived: sum of 2 quarters · filed 2017-02-23
-60.60K shares
derived: sum of 3 quarters · filed 2017-02-23
183.62K shares
10-K · filed 2017-02-23
2016-09-3034.80K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
121.78K shares
derived: sum of 2 quarters · filed 2016-11-03
366.00K shares
10-Q · filed 2016-11-03
406.33K shares
derived: sum of 4 quarters · filed 2016-11-03
2016-06-3086.98K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
331.20K shares
10-Q · filed 2016-08-04
371.53K shares
derived: sum of 3 quarters · filed 2016-08-04
417.88K shares
derived: sum of 4 quarters · filed 2016-08-04
2016-03-31244.22K shares
10-Q · filed 2016-05-05
284.55K shares
derived: sum of 2 quarters · filed 2016-05-05
330.89K shares
derived: sum of 3 quarters · filed 2016-05-05
372.16K shares
derived: sum of 4 quarters · filed 2016-05-05
2015-12-3140.33K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25
86.67K shares
derived: sum of 2 quarters · filed 2016-02-25
127.94K shares
derived: sum of 3 quarters · filed 2016-02-25
310.86K shares
10-K · filed 2016-02-25
2015-09-3046.35K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
87.61K shares
derived: sum of 2 quarters · filed 2015-11-05
270.53K shares
10-Q · filed 2015-11-05
314.53K shares
derived: sum of 4 quarters · filed 2015-11-05
2015-06-3041.26K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
224.18K shares
10-Q · filed 2015-08-06
268.18K shares
derived: sum of 3 quarters · filed 2015-08-06
305.18K shares
derived: sum of 4 quarters · filed 2015-08-06
2015-03-31182.92K shares
10-Q · filed 2015-05-08
226.92K shares
derived: sum of 2 quarters · filed 2015-05-08
263.92K shares
derived: sum of 3 quarters · filed 2015-05-08
422.19K shares
derived: sum of 4 quarters · filed 2015-05-08
2014-12-3144.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17
81.00K shares
derived: sum of 2 quarters · filed 2015-03-17
239.27K shares
derived: sum of 3 quarters · filed 2015-03-17
420.70K shares
10-K · filed 2015-03-17
2014-09-3037.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
195.27K shares
derived: sum of 2 quarters · filed 2014-11-07
376.70K shares
10-Q · filed 2014-11-07
402.70K shares
derived: sum of 4 quarters · filed 2014-11-07
2014-06-30158.27K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
339.70K shares
10-Q · filed 2014-08-11
365.70K shares
derived: sum of 3 quarters · filed 2014-08-11
518.70K shares
derived: sum of 4 quarters · filed 2014-08-11
2014-03-31181.43K shares
10-Q · filed 2014-05-09
207.43K shares
derived: sum of 2 quarters · filed 2014-05-09
360.43K shares
derived: sum of 3 quarters · filed 2014-05-09
423.48K shares
derived: sum of 4 quarters · filed 2014-05-09
2013-12-3126.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
179.00K shares
derived: sum of 2 quarters · filed 2014-03-14
242.05K shares
derived: sum of 3 quarters · filed 2014-03-14
567.05K shares
10-K · filed 2014-03-14
2013-09-30153.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
216.05K shares
derived: sum of 2 quarters · filed 2013-11-08
541.05K shares
10-Q · filed 2013-11-08
552.55K shares
derived: sum of 4 quarters · filed 2013-11-08
2013-06-3063.05K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07
388.05K shares
10-Q · filed 2013-08-07
399.55K shares
derived: sum of 3 quarters · filed 2013-08-07
662.55K shares
derived: sum of 4 quarters · filed 2013-08-07
2013-03-31325.00K shares
10-Q · filed 2013-05-07
336.50K shares
derived: sum of 2 quarters · filed 2013-05-07
599.50K shares
derived: sum of 3 quarters · filed 2013-05-07
2012-12-3111.50K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15
274.50K shares
derived: sum of 2 quarters · filed 2013-03-15
368.69K shares
10-K · filed 2013-03-15
2012-09-30263.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
357.19K shares
10-Q · filed 2012-11-08
2012-06-3094.19K shares
10-Q · filed 2012-08-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78